Imatinib mesylate plus hydroxyurea for adults with recurrent/progressive low-grade glioma: Final phase II study results.
Publication
, Journal Article
Peters, K; Desjardins, A; Vredenburgh, JJ; Dryman, B; Gururangan, S; Friedman, HS; Reardon, DA
Published in: Journal of Clinical Oncology
May 20, 2010
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2010
Volume
28
Issue
15_suppl
Start / End Page
2060 / 2060
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Peters, K., Desjardins, A., Vredenburgh, J. J., Dryman, B., Gururangan, S., Friedman, H. S., & Reardon, D. A. (2010). Imatinib mesylate plus hydroxyurea for adults with recurrent/progressive low-grade glioma: Final phase II study results. Journal of Clinical Oncology, 28(15_suppl), 2060–2060. https://doi.org/10.1200/jco.2010.28.15_suppl.2060
Peters, K., A. Desjardins, J. J. Vredenburgh, B. Dryman, S. Gururangan, H. S. Friedman, and D. A. Reardon. “Imatinib mesylate plus hydroxyurea for adults with recurrent/progressive low-grade glioma: Final phase II study results.” Journal of Clinical Oncology 28, no. 15_suppl (May 20, 2010): 2060–2060. https://doi.org/10.1200/jco.2010.28.15_suppl.2060.
Peters K, Desjardins A, Vredenburgh JJ, Dryman B, Gururangan S, Friedman HS, et al. Imatinib mesylate plus hydroxyurea for adults with recurrent/progressive low-grade glioma: Final phase II study results. Journal of Clinical Oncology. 2010 May 20;28(15_suppl):2060–2060.
Peters, K., et al. “Imatinib mesylate plus hydroxyurea for adults with recurrent/progressive low-grade glioma: Final phase II study results.” Journal of Clinical Oncology, vol. 28, no. 15_suppl, American Society of Clinical Oncology (ASCO), May 2010, pp. 2060–2060. Crossref, doi:10.1200/jco.2010.28.15_suppl.2060.
Peters K, Desjardins A, Vredenburgh JJ, Dryman B, Gururangan S, Friedman HS, Reardon DA. Imatinib mesylate plus hydroxyurea for adults with recurrent/progressive low-grade glioma: Final phase II study results. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010 May 20;28(15_suppl):2060–2060.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2010
Volume
28
Issue
15_suppl
Start / End Page
2060 / 2060
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences